MetLife (MET)
(Delayed Data from NYSE)
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
Zacks News
Earnings Preview: MetLife (MET) Q2 Earnings Expected to Decline
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can MetLife (MET) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
MetLife (MET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Regional Management (RM) Taps Indiana, Grows Base to 15th State
by Zacks Equity Research
With the expansion in Indiana, people with limited access to consumer credit are expected to benefit from Regional Management's (RM) secured credit products.
Here's Why You Should Add MetLife (MET) to Your Portfolio Now
by Zacks Equity Research
MetLife (MET) continues to benefit on the back of strong VII driving its margins, varied product launches, direct expense ratio below its targeted level and a strong cash position.
Is MetLife (MET) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Owl Rock Capital's (ORCC) Portfolio Company Acquires Liberty
by Zacks Equity Research
Owl Rock Capital (ORCC) expects the acquisition to create a premier equipment finance platform, which will be responsible for providing tailored financial solutions for the clients.
Why You Must Add American International (AIG) to Your Portfolio
by Zacks Equity Research
American International (AIG) is likely to buy back $3.9 billion of common shares by 2022 end.
Has BB Seguridade Participacoes (BBSEY) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Here is how BB Seguridade Participacoes SA (BBSEY) and MetLife (MET) have performed compared to their sector so far this year.
The Zacks Analyst Blog Highlights W. R. Berkley, Cincinnati Financial, American Financial Group, RLI and MetLife
by Zacks Equity Research
W. R. Berkley, Cincinnati Financial, American Financial Group, RLI and MetLife have been included in this Analyst Blog.
Top 5 Insurance Stocks to Play a Higher Interest Rate Regime
by Nalak Das
We have narrowed our search to five U.S.-based insurers. These are: WRB, RLI, AFG, MET and CINF.
Assurant (AIZ) Rallies 15% YTD: Can It Retain the Momentum?
by Zacks Equity Research
The well-performing Global Lifestyle business, growth in fee-based capital-light businesses and solid capital management continue to drive Assurant (AIZ).
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should You Retain Brighthouse (BHF) Stock in Your Portfolio?
by Zacks Equity Research
Brighthouse (BHF) is well poised for growth on the back of higher underwriting margin, strong annuity sales, lower expenses and prudent capital deployment.
Reasons to Hold Trupanion (TRUP) Stock in Your Portfolio Now
by Zacks Equity Research
Trupanion (TRUP) is poised to grow on a change in the attitude of pet owners who are focusing on pets' health and well-being in an underpenetrated pet insurance market, product launches and extended operating boundaries.
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, solid performance of automotive insurance providers and sufficient liquidity.
Why Is MetLife (MET) Down 0.7% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Insurance ETFs to Gain on Solid Q1 Earnings
by Sweta Killa
Take a look at insurance ETFs post Q1 earnings.
MetLife's (MET) Q1 Earnings Beat on Strong Latin America Unit
by Zacks Equity Research
MetLife's (MET) first-quarter earnings indicate higher premiums and a decline in expenses. A new share repurchase authorization worth $3 billion reflects MET's sound capital position.
MetLife (MET) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 27.61% and 3.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stock Q1 Earnings List for May 4: MET, ALL, AFG, LNC
by Kaibalya Pravo Dey
Reopening of business activities throughout the first quarter is likely to have aided the insurance stock results, offset by a soft pricing environment. MET, ALL, AFG and LNC are set to report earnings performance on May 4.
MetLife (MET) Gears Up for Q1 Earnings: What to Expect?
by Zacks Equity Research
MetLife's (MET) first-quarter results are likely to reflect lower net investment income and escalating costs due to technology investments, partly offset by revenue growth stemming from higher premiums.
Analysts Estimate MetLife (MET) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife's (MET) Arm MIM Closes $1.6B Private Equity Fund
by Zacks Equity Research
MetLife's (MET) business MIM used the secondaries market for third-party equity fund. The portfolio includes 80 fund positions across various sectors.
MetLife (MET) Arm Gets CBI License to Aid European Investors
by Zacks Equity Research
MetLife's (MET) institutional asset management business MIM receives a CBI authorization, which in turn, will help it deliver sound investment capabilities and benefit investors in the EEA.
Zacks Industry Outlook Highlights MetLife, American International Group, The Hartford Financial Services Group, Old Republic International, and Horace Mann Educators
by Zacks Equity Research
MetLife, American International Group, The Hartford Financial Services Group, Old Republic International, and Horace Mann Educators are part of today's industry outlook article.